LOVENOX

LOE Approaching

enoxaparin sodium

NDAINJECTIONINJECTABLEPriority Review
Approved
May 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Clinical Trials (5)

NCT02366871Phase 2Completed

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

Started Apr 2015
400 enrolled
Gynecologic CancerVenous Thromboembolism
NCT00916669Phase 2Withdrawn

A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Started Jul 2008
0
Small Cell Lung Cancer
NCT00521885N/ATerminated

Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients

Started Sep 2007
1 enrolled
Venous Thrombosis
NCT00349180Phase 3Completed

Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)

Started Jun 2006
156 enrolled
Arthroplasty, Replacement, Hip
NCT00232271Phase 4Terminated

The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.

Started Aug 2005
35 enrolled
Deep Vein Thrombosis